secwatch.observer — SEC 8-K summary
======================================

Issuer:     AtaiBeckley Inc. (ATAI)
CIK:        0002081043
Form:       8-K
Filed at:   2026-09-11T13:15:08+00:00
Accession:  0001140361-26-036283
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eli Lilly completes $6.75/share buyout of AtaiBeckley (ATAI); CVRs worth up to $2.50
--------------------------------------------------------------------------------

- Merger closed Sept 11: each ATAI share converted to $6.75 cash plus one CVR (up to $2.50) on milestones.
- CVR payments: $1.00 upon Phase 3 start of VLS-01 by 2030, $0.50 upon US approval/DEA reschedule of BPL-003, $1.00 on VLS-01.
- Company delisted from Nasdaq; Form 25 filed and Form 15 to follow, terminating SEC reporting.
- Board replaced: Lilly designees Christopher Anderson, Jonathan R. Haug become directors; Haug named President.
- $194,000 retention bonus granted to Gerd Kochendoerfer, payable after closing subject to continued employment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2081043/000114036126036283/0001140361-26-036283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2081043/000114036126036283/ef20081247_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-036283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer